#Evolocumab is second PCSK9 inhibitor approved to lower LDL in high-risk patients #FDA http://bit.ly/1Im8GDe
You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more
#Evolocumab is second PCSK9 inhibitor approved to lower LDL in high-risk patients #FDA http://bit.ly/1Im8GDe